![](/img/cover-not-exists.png)
Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
Paul W. Armstrong, Peter X. Adams, Hussein R. Al-Khalidi, Christian Hamm, David Holmes, William O'Neill, Thomas G. Todaro, Alec Vahanian, Frans Van de Werf, Christopher B. GrangerVolume:
149
Year:
2005
Language:
english
Pages:
408
DOI:
10.1016/j.ahj.2004.12.015
File:
PDF, 179 KB
english, 2005